Recall events
/
Event 64835
Event summary
Timeline bucket March 28, 2013
Product types Drug
Classifications Class II
Statuses Completed
Recalling firm wording Pfizer Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
11 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 11
Levoxyl (levothyroxine sodium) tablets, USP 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count bottles ( NDC 60793-850-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-251-2013
Recall number D-251-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 23210 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened..
Code information Lot # a) 66675B, Exp. 10/13; b) 66852B Exp. 10/13; 67138B, Exp. 02/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13756]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 11
Levoxyl (levothyroxine sodium) tablets, USP 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles ( NDC 60793-851-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-252-2013
Recall number D-252-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 29613 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened.
Code information Lot # a) 66730B, 66853B, Exp. 01/14; b) 66731B, 67116B, Exp. 11/13, 66856B, Exp. 12/13; 67341B, Exp, 02/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[14026]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 11
Levoxyl (levothyroxine sodium) tablets, USP 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles ( NDC 60793-852-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-253-2013
Recall number D-253-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 37809 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened.
Code information Lot # a) 66369B, Exp. 10/13; 66679B, Exp. 11/13; 66850B, Exp. 12/13; b) 66676B, 66732B, Exp. 12/13; 67136B, Exp. 03/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13563]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 11
Levoxyl (levothyroxine sodium) tablets, USP 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles ( NDC 60793-853-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-254-2013
Recall number D-254-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 26447 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened..
Code information Lot # a) 66619B, Exp. 11/13; 67010B, Exp. 01/14; b) 66733B, Exp. 11/13; 67441B, Exp. 01/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[14271]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 11
Levoxyl (levothyroxine sodium) tablets, USP 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles ( NDC 60793-854-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-255-2013
Recall number D-255-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 18195 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened..
Code information Lot # a) 66897B, Exp. 12/13; b) 67137B, Exp.02/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13761]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 11
Levoxyl (levothyroxine sodium) tablets, USP 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles ( NDC 60793-855-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-256-2013
Recall number D-256-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 9213 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened.
Code information Lot # a) 67343B, Exp. 01/14; b) 66902B, Exp. 12/13
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[14300]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 11
Levoxyl (levothyroxine sodium) tablets, USP 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles ( NDC 60793-856-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-257-2013
Recall number D-257-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 37891 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened
Code information Lot # a) 66373B, Exp. 10/13; 66851B, Exp. 12/13; b)66792B, Exp. 12/13; 67349B, Exp. 03/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[836]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 11
Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60793-857-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-258-2013
Recall number D-258-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 7901 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened.
Code information Lot # a) 67013B, Exp. 01/14; b) 66900B, Exp. 01/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[14276]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 11
Levoxyl (levothyroxine sodium) tablets, USP 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles ( NDC 60793-858-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-259-2013
Recall number D-259-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 36045 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened.
Code information Lot # a) 66375B, Exp. 10/13; 66719B, Exp. 01/14; b) 66904B, Exp. 01/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13590]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 11
Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60793-859-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-260-2013
Recall number D-260-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 10121 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened.
Code information Lot # a) 67507B, Exp. 02/14; b) 67508B, Exp. 02/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[14083]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 11
Levoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles ( NDC 60793-860-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.
D-261-2013
Recall number D-261-2013
Initiated March 28, 2013
Classification Class II
Status Completed
Quantity 14464 bottles
App-derived interpretation
Foreign material or chemical contamination
reason.foreign_material_chemical_contamination · v1.0.0
Chemical contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Chemical contamination: emission of strong odor after package was opened.
Code information Lot # a) 66671B, Exp. 11/13; 67512B, Exp. 02/14 b) 66739B Exp. 11/13; 67513B Exp. 02/14
Distribution pattern Nationwide and PR
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[838]
FDA event record
· Exact recall-number query on openFDA
